Tasly Pharmaceutical Group Co (SHSE:600535) Days Sales Outstanding : 38.88 (As of Mar. 2025)

View and export this data going back to 2002. Start your Free Trial

What is Tasly Pharmaceutical Group Co Days Sales Outstanding?

Tasly Pharmaceutical Group Co's average Accounts Receivable for the three months ended in Mar. 2025 was ¥876 Mil. Tasly Pharmaceutical Group Co's Revenue for the three months ended in Mar. 2025 was ¥2,055 Mil. Hence, Tasly Pharmaceutical Group Co's Days Sales Outstanding for the three months ended in Mar. 2025 was 38.88.

The historical rank and industry rank for Tasly Pharmaceutical Group Co's Days Sales Outstanding or its related term are showing as below:

SHSE:600535' s Days Sales Outstanding Range Over the Past 10 Years
Min: 31.53 Med: 118.87 Max: 160.45
Current: 38.6

During the past 13 years, Tasly Pharmaceutical Group Co's highest Days Sales Outstanding was 160.45. The lowest was 31.53. And the median was 118.87.

SHSE:600535's Days Sales Outstanding is ranked better than
83.28% of 957 companies
in the Drug Manufacturers industry
Industry Median: 72.09 vs SHSE:600535: 38.60

Tasly Pharmaceutical Group Co's Days Sales Outstanding increased from Mar. 2024 (33.94) to Mar. 2025 (38.88).

Tasly Pharmaceutical Group Co Days Sales Outstanding Historical Data

The historical data trend for Tasly Pharmaceutical Group Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tasly Pharmaceutical Group Co Days Sales Outstanding Chart

Tasly Pharmaceutical Group Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Days Sales Outstanding

Get a 7-Day Free Trial

138.50

72.68

46.29

33.33

31.53

Tasly Pharmaceutical Group Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Days Sales Outstanding	Get a 7-Day Free Trial															33.94	33.48	41.66	40.81	38.88

Competitive Comparison of Tasly Pharmaceutical Group Co's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Tasly Pharmaceutical Group Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tasly Pharmaceutical Group Co's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tasly Pharmaceutical Group Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Tasly Pharmaceutical Group Co's Days Sales Outstanding falls into.

Save Embed

;

Save Embed

;

Tasly Pharmaceutical Group Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Tasly Pharmaceutical Group Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2024 is calculated as

	Days Sales Outstanding (A: Dec. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )	/	Revenue (A: Dec. 2024 )	*	Days in Period
=	( (688.003	+	780.137)	/	2 )	/	8498.142	*	365
=	734.07					/	8498.142	*	365
=	31.53

Tasly Pharmaceutical Group Co's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

	Days Sales Outstanding (Q: Mar. 2025 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2024 )	+	Accounts Receivable (A: Mar. 2025 ))	/	count )	/	Revenue (A: Mar. 2025 )	*	Days in Period
=	( (780.137	+	970.95)	/	2 )	/	2054.886	*	365 / 4
=	875.5435					/	2054.886	*	365 / 4
=	38.88

Tasly Pharmaceutical Group Co (SHSE:600535) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Tasly Pharmaceutical Group Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Tasly Pharmaceutical Group Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Tasly Pharmaceutical Group Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tasly Pharmaceutical Group Co Ltd (SHSE:600535) » Definitions » Days Sales Outstanding

Traded in Other Exchanges

N/A

Address

2 Pujihe Road East, Beichen District, Tasly TCM Garden, Tianjin, CHN, 300410

Website

http://www.tasly.com

Tasly Pharmaceutical Group Co Ltd is a China-based company engaged in the manufacturing and distribution of pharmaceutical products. Its herbal medicines include Tasly Cerebral Care Granules and Tasly ICP. Its chemical medicines comprise of Ketotifen Fumarate Tablets, Thiamphenicol Capsules, Glucurolactone Tablets and Sulpiride Tablets. Some of the other products offered by the company include PharmceuticalSubstances & API, HerbalExtract, and Concentrated Herbal Granules.

Executives

Wu Nai Feng

Director

Tasly Pharmaceutical Group Co Headlines

No Headlines